Search TCMD
TACTILE SYSTEMS TECHNOLOGY INC
Nasdaq · CIK 1027838
Last close22.1
Daily change+0.39 (1.80%)
10 Years gain+19.78%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
TCMD · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
64.4Momentum
71.7Acceleration
71.7Confidence
85.0Annual Revenue12
Quarterly Revenue51
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.8 / 25
Quality20.3 / 25
Capital Efficiency8.1 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.207 percentage points.
Operating leverageOperating margin improved by 4.3386 percentage points.
Share count reductionDiluted share count declined 2.7487%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM21.2%OK
Revenue CAGR 3Y10.12%OK
Gross Margin75.78%OK
Operating Margin6.25%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC10.92%OK
Incremental Operating Margin 3Y58.35%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.75%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $329.52M | $250.15M | $29.28M | $42.81M | $40.43M | 75.91% | 8.89% | 12.27% | 14.77% | 23.3M |
| 2025 FY Dec 31, 2024 | $292.98M | $216.69M | $22.18M | $40.66M | $38.26M | 73.96% | 7.57% | 13.06% | 12.57% | 24.14M |
| 2025 FY Dec 31, 2023 | $274.42M | $195.13M | $18.04M | $35.86M | $33.53M | 71.11% | 6.57% | 12.22% | 10.11% | 23.18M |
| 2024 FY Dec 31, 2022 | $246.79M | $175.98M | -$12.76M | $5.21M | $3.43M | 71.31% | -5.17% | 1.39% | -10.11% | 20.07M |
| 2023 FY Dec 31, 2021 | $208.06M | $148.21M | -$1.76M | $2.63M | $528,000.00 | 71.24% | -0.85% | 0.25% | -1.57% | 19.72M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $325.63M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-093352, 0001104659-25-105543 |
| Revenue Growth TTM | 21.2% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-093352, 0001104659-25-105543 |
| Revenue CAGR 3Y | 10.12% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-016380 |
| Revenue CAGR 5Y | 11.98% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104659-26-016380 |
| Gross Profit CAGR 3Y | 12.44% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-016380 |
| Operating Income Growth | 296.92% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001104659-26-093352, 0001104659-25-105543 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 75.78% | Gross Profit / Revenue | OK | 0001104659-26-093352, 0001104659-25-105543 |
| Operating Margin | 6.25% | Operating Income / Revenue | OK | 0001104659-26-093352, 0001104659-25-105543 |
| ROIC | 10.92% | NOPAT / Average Invested Capital | OK | 0001104659-26-093352, 0001104659-25-105543 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-093352 |
| Current Ratio | 4.12x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $14.12 | Revenue / Diluted Shares | OK | 0001104659-26-093352, 0001104659-25-105543 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |